Regulating the immune response to tumours

This publication has 74 references indexed in Scilit:

• Intra-tumoural regulatory T cells: A potential new target in cancer immunotherapy
  Biochemical and Biophysical Research Communications, 2006
• Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
  Journal of Clinical Investigation, 2005
• CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
  The Journal of Experimental Medicine, 2005
• Regulation of immunity by self-reactive T cells
  Nature, 2005
• Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
  Immunity, 2005
• CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
  European Journal of Immunology, 2004
• Adoptive-cell-transfer therapy for the treatment of patients with cancer
  Nature Reviews Cancer, 2003
• CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms
  The Journal of Experimental Medicine, 2003
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
  The Journal of Experimental Medicine, 2001
• Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.
  The Journal of Experimental Medicine, 1984